Second quarter 2021 earnings released: EPS US$6.92 (vs US$0.31 loss in 2Q 2020)
The company reported a strong second quarter result with improved earnings, revenues and profit margins.Second quarter 2021 results:
- Revenue: US$4.35b (up US$4.29b from 2Q 2020).
- Net income: US$2.78b (up US$2.90b from 2Q 2020).
- Profit margin: 64% (up from net loss in 2Q 2020). The move to profitability was driven by higher revenue.
Moderna, Inc. (NasdaqGS:MRNA) announces an Equity Buyback for $1,000 million worth of its shares.
Moderna, Inc. (NasdaqGS:MRNA) announces a share repurchase program. Under the program, the company will repurchase up to $1,000 million worth of its shares. The purpose of the program is to return excess capital to shareholders. The program will be valid for a period of 2 years.
Price target increased to US$226
Up from US$179, the current price target is an average from 14 analysts.
- New target price is 45% below last closing price of US$414.
- Stock is up 458% over the past year.